In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...

DermaSensor announced newly published studies supporting the performance of its device for evaluating suspicious skin lesions ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

Symmetrical—lesions appear to be distributed in a similar arrangement on differing sides of the body (Figure 3, see slideshow) Once the configuration and distribution has been determined, the next ...

Enspectra Health today announced the publication of pivotal clinical trial results in JAMA Dermatology, demonstrating that its handheld cross-modal imaging system enables physicians to accurately ...

“It could empower patients and primary care providers to monitor suspicious skin lesions and seek help sooner.” He says the ...

Tens of millions of Americans develop sun-linked skin lesions called actinic keratoses, which are tied to later cancer risk. Many will get a combo of treatments to help clear the blemishes. Now, ...

An artificial intelligence (AI)–enabled handheld elastic scattering spectroscopy (ESS) device improved the sensitivity for skin cancer diagnosis and management by primary care physicians (PCPs), with ...

Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) ...

Recent vitiligo research has challenged long-held assumptions about skin cancer risk in patients with depigmented lesions. A ...

A 5-year-old boy is referred from an Army hospital in Panama in the mid-1980s to Brooke Army Medical Center for evaluation of an unrelated problem when his parent asked about a case of several ...

This is likely the first case report on primary cutaneous follicle center lymphoma associated with bone marrow mastocytosis.